Listed by the USPTO as WESTERBERG, NISSA M
Tech Center 4100 • Art Units: 1618 4100
This examiner grants 23% of resolved cases
WESTERBERG, NISSA M is assigned to Tech Center 4100 and Art Unit 1618. Her record includes 913 resolved cases, an allowance rate of 23.4%, and a median of 1569 days to allowance. The 37.3% interview lift is strongly positive in this record, indicating that interviews may materially improve outcomes even though the overall allowance rate remains low.
The listed companies are California Institute of Technology, Curium US LLC, and University of Florida Research Foundation Inc. The listed firms are POLSINELLI PC (Main Customer Number), Advent, LLP, and Anderson Patent Law Firm LLC. Practitioners should treat interview preparation as a central part of prosecution, particularly where claim construction or technical distinctions can be explained directly. The 1569-day median also supports early attention to compact prosecution and amendment strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17906508 | DEUTERIUM MAGNETIC RESONANCE IMAGING | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18797888 | Octreotide Depot Formulation with Constantly High Exposure Levels | Non-Final OA | Novartis AG |
| 17795143 | FLUORESCENT SILICA NANOPARTICLES AND METHOD FOR MANUFACTURING FLUORESCENT SILICA NANOPARTICLES | Non-Final OA | Konica Minolta, Inc. |
| 18424697 | STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY | Non-Final OA | Wisconsin Alumni Research Foundation |
| 19345876 | IMPROVED LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE | Final Rejection | Neocaine, LLC |
| 17308599 | CATIONIC MUCIC ACID POLYMER-BASED DELIVERY SYSTEMS | Final Rejection | California Institute Of Technology |
| 17092215 | REMOTE-CONTROLLED IMAGE-GUIDED DRUG DELIVERY VIA ULTRASOUND-MODULATED MOLECULAR DIFFUSION | Non-Final OA | California Institute of Technology |
| 17445285 | ENHANCING SUBCUTANEOUS INJECTION AND TARGET TISSUE ACCUMULATION OF NANOPARTICLES VIA CO-ADMINISTRATION WITH MACROPINOCYTOSIS INHIBITORY NANOPARTICLES (MINP) | Final Rejection | Northwestern University |
| 18550964 | COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF | Non-Final OA | Purdue Research Foundation |
| 18551786 | ORAL DELIVERY OF SILICA/ALUMINOSILICATE NANOPARTICLES | Non-Final OA | Cornell University |
| 18166390 | METHODS AND COMPOSITION FOR DYE-BASED ENCODING AND QUANTIFICATION | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 17403157 | COSMETIC COMPOSITIONS | Final Rejection | L'Oreal |
| 18904575 | Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells | Final Rejection | The Trustees of the University of Pennsylvania |
| 17606226 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | Non-Final OA | ACTINIUM PHARMACEUTICALS, INC. |
| 18031760 | PROCESSES FOR SYNTHESIS OF ALPHA-EMITTING RADIOPHARMACEUTICALS | Non-Final OA | UNIVERSITY OF IOWA RESEARCH FOUNDATION |
| 18445604 | Formulated and/or Co-Formulated Liposome Compositions Containing Toll-Like Receptor ("TLR") Agonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof C | Final Rejection | Nammi Therapeutics, Inc. |
| 18040021 | ALPHA RADIOLABELED GASTRIN ANALOGUE AND USE THEREOF IN METHODS OF TREATING CCKB RECEPTOR POSITIVE DISEASES | Non-Final OA | Paul Scherrer Institut |
| 18570180 | Contrast agent for magnetic resonance imaging | Non-Final OA | Betavist GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy23.4% of resolved applications examined by Nissa M Westerberg were allowed (913 resolved cases), compared with 33.1% across Art Unit 1618 over the last five years.
This examiner's interview lift is +37.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Nissa M Westerberg took 1,569 days on average from filing to allowance.
Nissa M Westerberg examines applications in Art Unit 1618 in Tech Center 4100.
